FrancophonIA/ELRC3.0 huggingface dataset:
English: DATE OF REVISION OF THE TEXT <{DD month YYYY}> [To be completed nationally]
Slovenian: DATUM ZADNJE REVIZIJE BESEDILA {DD. mesec LLLL}
English: Generally, the transdermal route is not recommended in opioid-naïve patients.
Slovenian: Bolniki, ki še niso prejemali opioidov Na splošno transdermalna uporaba pri bolnikih, ki še niso prejemali opioidov, ni priporočljiva.
English: within 14 days of stopping these medicines.
Slovenian: Zdravila DUROGESIC ne smete jemati še 14 dni po prenehanju jemanja teh zdravil.
English: The analgesic effect of the first dose of DUROGESIC patches will not be optimal within the first 24 hours.
Slovenian: Analgetični učinek prvega odmerka transdermalnega obliža DUROGESIC v prvih 24 urah ne bo optimalen, zato mora bolnik prvih 12 ur po prehodu na transdermalni obliž DUROGESIC še vedno dobivati predhodne analgetike v enakem odmerku kot prej.
English: • Fits (seizures).
Slovenian: • Napadi krčev (epileptični krči).
English: Convert this amount to the equianalgesic 24-hour oral morphine dose using the multiplication factors in Table 1 for the appropriate route of administration.
Slovenian: Dobljeno vrednost pretvorite v odgovarjajočo 24-urno vrednost za peroralno uporabo morfina.
English: Application site reaction, Influenzalike illness, Feeling of body temperature change,
Slovenian: občutek spremenjene telesne temperature,
English: Step 4: Disposing of the patch
Slovenian: 3. korak: Odstranite zaščitno folijo in pritisnite
English: A new patch should be applied to a different skin site after removal of the previous transdermal patch.
Slovenian: Po odstranitvi starega transdermalnega obliža novega prilepimo na drugo mesto.
English: BATCH NUMBER
Slovenian: ŠTEVILKA SERIJE Št. serije:
English: • DUROGESIC may cause constipation, talk to your doctor or pharmacist for advice on how to prevent or relieve constipation.
Slovenian: Zdravnika ali farmacevta vprašajte za nasvet, kako preprečiti ali lajšati zaprtje.
English: Tolerance, physical dependence, and psychological dependence may develop upon repeated administration of opioids.
Slovenian: Po večkratni uporabi opioidov se lahko pojavi toleranca ter telesna in duševna odvisnost.
English: Table 4: Recommended DUROGESIC dosage for paediatric patients1 based upon daily oral morphine dose2
Slovenian: Preglednica 4: Priporočeni odmerek zdravila DUROGESIC pri pediatričnih bolnikih1, glede na dnevni peroralni odmerek morfina2 Peroralni 24-urni odmerek morfina (mg/dan)
English: What DUROGESIC is and what it is used for
Slovenian: Kaj je zdravilo DUROGESIC in za kaj ga uporabljamo Vaše zdravilo se imenuje DUROGESIC.
English: Caution is advised upon concomitant use of CYP3A4 inducers and DUROGESIC.
Slovenian: Pri sočasni uporabi induktorjev CYP3A4
English: • Being short of breath (dyspnoea)
Slovenian: • zadihanost (dispneja)
English: If patients with hepatic impairment receive DUROGESIC, they should be observed carefully for signs of fentanyl toxicity and the dose of DUROGESIC reduced if necessary (see section
Slovenian: Če bolniki z okvaro jeter prejemajo zdravilo DUROGESIC, jih je treba skrbno spremljati glede znakov toksičnih učinkov fentanila in jim odmerek zdravila DUROGESIC po potrebi zmanjšati (glejte poglavje 5.2).
English: Side effects and DUROGESIC
Slovenian: Neželeni učinki in zdravilo DUROGESIC
English: DUROGESIC should not be administered to opioid-naïve paediatric patients (see section 4.2).
Slovenian: Zdravila DUROGESIC ne smete uporabljati pri otrocih, ki še niso prejemali opioidov (glejte poglavje 4.2).
English: Centrally-acting medicinal products and alcohol
Slovenian: Imetnik dovoljenja za promet z zdravilom in izdelovalec
English: Anaphylactic shock,
Slovenian: Psihiatrične motnje nespečnost,
English: Serotonin syndrome may include mental-status changes (eg, agitation, hallucinations, coma), autonomic instability (eg, tachycardia, labile blood pressure, hyperthermia), neuromuscular abnormalities (eg, hyperreflexia, incoordination, rigidity), and/or gastrointestinal symptoms (eg, nausea, vomiting, diarrhoea).
Slovenian: halucinacije, komo), avtonomno nestabilnost (npr. tahikardijo, spremenljiv krvni tlak, hipertermijo),
English: Skin does not appear to metabolise fentanyl delivered transdermally.
Slovenian: Transdermalno vnešeni fentanil se v koži ne presnavlja.
English: 6.5 Nature and contents of container [To be completed nationally]
Slovenian: 6.5 Vrsta ovojnine in vsebina
English: Generally, a patient should wait for 2 days after stopping treatment with a CYP3A4 inhibitor before applying the first DUROGESIC patch.
Slovenian: šele 2 dni po prekinitvi zdravljenja z zaviralci CYP3A4.
English: STATEMENT OF ACTIVE SUBSTANCE(S) [To be completed nationally]
Slovenian: NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN [izpolni država članica]
English: You should check with your doctor or pharmacist if you are not sure.
Slovenian: posvetujte z zdravnikom ali farmacevtom.
English: Fatigue, Oedema peripheral, Asthenia, Malaise, Feeling cold
Slovenian: Bolezni živčevja somnolenca, omotica, glavobol tremor, parestezija hipestezija, konvulzije
English: Bradypnoea
Slovenian: OVOJNINAH
English: Therefore, they must keep all patches out of the sight and reach of children, both before and after use.
Slovenian: Zato je treba vse obliže (neuporabljene in uporabljene) shranjevati nedosegljivo otrokom.
English: • If you get side effects talk to your doctor, pharmacist or nurse.
Slovenian: - Če opazite kateri koli neželeni učinek, se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro.
English: DUROGESIC contains {name the excipient(s)
Slovenian: DUROGESIC ali morfin).
English: • Feeling dizzy
Slovenian: • suha usta
English: Talk to your doctor or pharmacist if you are not sure whether it is safe for you to drive while taking this medicine.
Slovenian: Če niste prepričani ali je med uporabo tega zdravila varno voziti, se o tem pogovorite z zdravnikom ali farmacevtom.
English: • Keep this leaflet.
Slovenian: Upoštevajte zgornji nasvet.
English: Nausea, Vomiting, Constipation
Slovenian: (npr. navzeo, bruhanje, drisko).
English: DUROGESIC can affect your ability to drive and use machines or tools as it may make you sleepy or dizzy.
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev Zdravilo DUROGESIC lahko vpliva na sposobnost upravljanja vozil in strojev.
English: Date of first authorization: 15 June 2017
Slovenian: Datum prve odobritve: 15 junij 2017
English: This may be months from now.
Slovenian: To je lahko šele čez nekaj mesecev.
English: − CI = confidence interval.
Slovenian: - IZ = interval zaupanja.
English: Why have I been given this card?
Slovenian: Zakaj ste prejeli to kartico?
English: Each cycle has a duration of 28 days.
Slovenian: Dolžina vsakega cikla je 28 dni.
English: If you feel dizzy, do not drive or use any tools or machines.
Slovenian: Če ste omotični, ne vozite ali ne uporabljajte nobenih orodij ali strojev.
English: 95.1%b CI (-3.2%, 24.3%)a
Slovenian: 95,1 %b IZ (−3,2 %, 24,3 %)a
English: It is important that you keep this Alert Card and show it to your partner or caregiver.
Slovenian: Pomembno je, da to kartico hranite pri sebi in da jo pokažete svojemu partnerju ali skrbniku.
English: This is usually given every 3 week up to 8 times.
Slovenian: Ta se po navadi daje na 3 tedne, do osemkrat.
English: Date of most recent infusion: __________ Date of first infusion: ________________ Patient's Name:_____________________ Doctor's Name:_____________________ Doctor's contact details:______________
Slovenian: Datum zadnjega infundiranja:____________ Datum prvega infundiranja:______________ Bolnikovo ime: _______________________ Zdravnikovo ime:______________________ Zdravnikov telefon:____________________
English: Some infections may be severe (please see information on Infections within this section).
Slovenian: Nekatere okužbe so lahko hude (prosimo glejte informacije pod naslovom Okužbe v tem poglavju).
English: • Changes in laboratory tests carried out by your doctor.
Slovenian: • spremembe rezultatov laboratorijskih preiskav, ki jih naroči vaš zdravnik.
English: It is important to check the medicinal product labels to ensure that the appropriate formulation is being given to the patient, as prescribed.
Slovenian: Pomembno je preveriti nalepke na zdravilu in tako zagotoviti, da bolnik dobi ustrezno obliko, ki mu je bila predpisana.
English: − * Worst case imputation a Non-inferiority was demonstrated since the lower bound (− 3.2%) was higher than the predetermined non-inferiority margin (− 20%).
Slovenian: - * Imputacija za najslabši primer a Neinferiornost je bila dokazana, ker je bila spodnja meja (−3,2 %) višja od vnaprej opredeljene meje neinferiornosti (−20 %).
English: The prespecified non-inferiority margin for the treatment difference was 20%.
Slovenian: Vnaprej opredeljena meja neinferiornosti za razliko zdravljenj je bila 20 %.
English: • a reduction in white blood cells which does not happen straight away
Slovenian: • zmanjšanje števila belih krvnih celic, ki se ne pojavi takoj,
English: As the Patient Alert Card is part of the product information in the outer packaging, the content will be centrally approved for all EU/EEA languages without need of further approval by National Authorities.
Slovenian: Ker je opozorilna kartica za bolnika del povzetka glavnih značilnosti zdravila v zunanjem pakiranju, bo njena vsebina centralno odobrena za vse jezike EU/EGS, pri čemer dodatna odobritev s strani nacionalnih organov ni potrebna.
English: The incidence of serious infections was similar in both arms (approximately 12%).
Slovenian: Pojavnost resnih okužb je bila v obeh skupinah podobna (približno 12 %).
English: Alternative subsequent, faster, infusion schedule
Slovenian: Alternativna nadaljnja, hitrejša infuzija
English: The risk of disease progression was reduced by 46% and the risk of relapse by 51%.
Slovenian: Tveganje za napredovanje bolezni je bilo manjše za 46 %, tveganje za ponovitev bolezni pa za 51 %.
English: All IRRs were CTC Grade 1 or 2.
Slovenian: IRR so bile 1. ali 2. stopnje po CTC.
English: Do not have Rixathon if you have an active infection or a serious problem with your immune system.
Slovenian: Zdravila Rixathon ne smete prejeti, če imate aktivno okužbo ali resno težavo s svojim imunskim sistemom.
English: • you have a weak immune system.
Slovenian: • imate oslabel imunski sistem;
English: Both tests are commonly positive in rheumatoid arthritis and aid in confirming the diagnosis.
Slovenian: Oba testa sta pri revmatoidnem artritisu običajno pozitivna in pomagata pri potrditvi diagnoze.
English: Do not use this medicine after the expiry date which is stated on the carton after EXP.
Slovenian: Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli poleg oznake »EXP«.
English: Your doctor will decide if you should receive concomitant supportive therapy.
Slovenian: Zdravnik se bo odločil, ali boste sočasno prejeli tudi podporno zdravljenje.
English: • high or low blood pressure (low blood pressure especially when standing upright)
Slovenian: • visok ali nizek krvni tlak (nizek krvni tlak zlasti po hitrem vstajanju),
English: Preparation should be: - performed under aseptic conditions by trained personnel in accordance with good practice rules especially with respect to the aseptic preparation of parenteral products.
Slovenian: Zdravilo mora: - pripraviti usposobljeno osebje v aseptičnih pogojih v skladu s pravili dobre prakse, še zlasti glede aseptične priprave parenteralnih zdravil
English: Available data suggest that clinical response is usually achieved within 16 to 24 weeks of an initial treatment course.
Slovenian: Podatki, ki so na voljo, kažejo, da je klinični odziv ponavadi dosežen v roku 16-24 tednov po začetnem ciklu zdravljenja.
English: Binet stage A Binet stage B Binet stage C CI: Confidence Interval
Slovenian: stopnja po Binetu A stopnja po Binetu B stopnja po Binetu C IZ: interval zaupanja
English: Patients should receive Rixathon for at least 24 months after achievement of remission (absence of clinical signs and symptoms).
Slovenian: Rixathon prejemati vsaj 24 mesecev po doseženi remisiji (odsotnost kliničnih znakov in simptomov).
English: If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2°C - 8°C, unless dilution has taken place in controlled and validated aseptic conditions.
Slovenian: Če je ne uporabimo takoj, je za čas in pogoje shranjevanja pred uporabo odgovoren uporabnik; čas običajno ne sme presegati 24 ur pri temperaturi od 2 °C do 8 °C, razen če je bila raztopina pripravljena v nadzorovanih in validiranih aseptičnih pogojih.
English: Premedication and prophylactic medications
Slovenian: Premedikacija in profilaktična zdravila
English: • long lasting depression
Slovenian: • dolgotrajna depresija,
English: These include a decrease in the amount of some specific proteins in the blood (immunoglobulins) which help protect against infection.
Slovenian: Te vključujejo zmanjšanje količine nekaterih specifičnih beljakovin v krvi (imunoglobulinov), ki pomagajo varovati pred okužbami.
English: Your doctor may decide to treat you longer with Rixathon (up to 5 years), depending on how you respond to the medicine.
Slovenian: Zdravnik se lahko odloči, da vas bo z zdravilom Rixathon zdravil dlje (do 5 let), odvisno od tega, kako se odzovete na zdravilo.
English: Table 14 Physical Function and Quality of Life outcomes at week 24 in Trial 1
Slovenian: Funkcijska zmogljivost in vpliv na kakovost življenja po 24 tednih v preskušanju 1
English: Of 356 patients evaluated for anti-drug antibody (ADA), 1.1% (4 patients) were positive.
Slovenian: Od 356 bolnikov, pri katerih so ocenjevali prisotnost protiteles proti zdravilu (anti-drug antibody - ADA), so bili pozitivni 4 bolniki (1,1 %).
English: • asthma, too little oxygen reaching the body organs
Slovenian: • astma, telesne organe doseže premalo kisika,
English: Percent age of Patients with First Major Relapse
Slovenian: Odstotek bolnikov s prvim hujšim recidivom
English: * at end of maintenance/observation; final analysis results based on median follow-up of 73 months.
Slovenian: * ob koncu vzdrževalnega zdravljenja/spremljanja; rezultati končne analize temeljijo na mediani spremljanja
English: • Show this card to any doctor, nurse or dentist you see - not just the specialist who prescribes your Rixathon.
Slovenian: • Pokažite jo vsem zdravnikom, medicinskim sestram in zobozdravnikom, ki jih obiščete - ne samo specialistu, ki vam predpiše zdravilo Rixathon.
English: Complete remission All patients Newly diagnosed Relapsing
Slovenian: Popolna remisija Vsi bolniki Novoodkriti Ponovitev
English: Rituximab was detectable in the serum of patients 3 to 6 months after completion of last treatment.
Slovenian: Rituksimab je bilo mogoče zaznati v serumu bolnikov 3 do 6 mesecev po zaključku zadnjega zdravljenja.
English: The need for further courses should be evaluated 24 weeks following the previous course.
Slovenian: Potrebo po nadaljnjih ciklih zdravljenja je treba oceniti 24 tednov po predhodnem ciklu.
English: Your doctor may decide to stop your Rixathon treatment if these reactions are serious.
Slovenian: Zdravnik se lahko odloči za prenehanje zdravljenja z zdravilom Rixathon, če so te reakcije resne.
English: Rixathon will be given to you by a doctor or nurse who is experienced in the use of this treatment.
Slovenian: Zdravilo Rixathon vam bo dal zdravnik ali medicinska sestra, ki ima izkušnje z uporabo takšnih zdravil.
English: Rixathon may also cause changes in laboratory tests carried out by your doctor.
Slovenian: Zdravilo Rixathon lahko vpliva tudi na spremembe laboratorijskih preiskav, ki jih naroči vaš zdravnik.
English: • mood disorders such as irritability and depression
Slovenian: • spremembe razpoloženja, kot sta razdražljivost in depresija,
English: It remains unknown if early detection of PML and suspension of rituximab therapy may lead to similar stabilisation or improved outcome.
Slovenian: Ni znano, ali lahko zgodnje odkritje PML in ukinitev zdravljenja z rituksimabom doseže podobno stabilizacijo ali izboljšanje izida.
English: The safety and efficacy of rituximab in children below 18 years have not been established.
Slovenian: Varnost in učinkovitost rituksimaba pri otrocih do 18. leta starosti nista dokazani.
English: • Excess fluid retention in the face and body
Slovenian: • zadrževanje odvečne tekočine v obrazu in telesu,
English: Patients were followed beyond week 24 for long term endpoints, including radiographic assessment at 56 weeks and at 104 weeks.
Slovenian: Bolnike so od 24. tedna spremljali za dolgoročne cilje študije in naredili tudi radiološko oceno po 56 tednih ter 104 tednih.
English: Population pharmacokinetic analysis of the same data gave similar mean values for systemic clearance and half-life, 0.26 L/day and 20.4 days, respectively.
Slovenian: Populacijska farmakokinetična analiza istih podatkov je dala podobne povprečne vrednosti za sistemski očistek in razpolovni čas, 0,26 l/dan in 20,4 dni.
English: • ringing sound in the ears, ear pain
Slovenian: • zvonjenje v ušesih, bolečine v ušesu,
English: If you can get pregnant, you and your partner must use an effective method of contraception while using Rixathon.
Slovenian: Če bi lahko zanosili, morate vi in vaš partner med uporabo zdravila Rixathon uporabljati učinkovito kontracepcijsko zaščito.
English: • reduced platelets number just after the infusion - this can be reversed, but can be fatal in rare cases
Slovenian: • zmanjšanje števila trombocitov tik po infundiranju zdravila - to je mogoče odpraviti, a v redkih primerih je lahko smrtno,
English: Retreatment should be given at that time if residual disease activity remains, otherwise retreatment should be delayed until disease activity returns.
Slovenian: Ob tem času je treba bolnika ponovno zdraviti, če je bolezen še vedno aktivna, sicer pa se ponovno zdravljenje odloži, dokler bolezen spet ne postane aktivna.
English: 1 Events were considered ADRs only after thorough assessment and where a causal relationship between the medicinal product and the adverse event was at least a reasonable possibility.
Slovenian: 1 Dogodke so kot neželene učinke ocenili šele po natančni oceni in v primerih, v katerih je bila vzročna povezanost med zdravilom in neželenim učinkom vsaj smiselna možnost.
English: The transient IgM increase usually returned to at least baseline level within 4 months.
Slovenian: Prehodna zvišanja IgM so se običajno vrnila vsaj na raven pred zdravljenjem v 4 mesecih.
English: • Cardiovascular events, see section 4.4.
Slovenian: • kardiovaskularni dogodki, glejte poglavje 4.4.
English: Tell your doctor immediately if you experience any of these symptoms.
Slovenian: Nemudoma povejte zdravniku, če se pri vas pojavi kateri od teh simptomov.
English: All patients Newly diagnosed Relapsing n=99 n=48 n=51
Slovenian: Vsi bolniki Novoodkriti Ponovitev n = 99 n = 48 n = 51
English: 2Details on infusion related reactions are provided in the description of selected adverse drug reactions section.
Slovenian: 2 Podrobnosti o reakcijah, povezanih z infundiranjem, so navedene v opisu v poglavju o izbranih neželenih učinkih zdravila.
English: The incidence of IRR symptoms was highest during or after the first infusion (9%) and decreased with subsequent infusions (<4%).
Slovenian: Pojavnost simptomov IRR je bila največja med prvo infuzijo ali po njej (9 %) in se je ob nadaljnjih infuzijah zmanjšala (< 4 %).
English: Aseptic handling must be ensured when preparing the infusion.
Slovenian: Pri pripravi infuzije je treba zagotoviti aseptično rokovanje.
English: Severe infusion-related reactions (such as bronchospasm, hypotension) occurred in up to 12% of the cases.
Slovenian: Hude reakcije, povezane z infuzijo (npr. bronhospazem, hipotenzija), so se pojavile pri do 12 % bolnikov.
English: Rixathon in combination with chemotherapy destroys these cells which are gradually removed from the body by biological processes.
Slovenian: Zdravilo Rixathon v kombinaciji s kemoterapijo uniči te celice, ki se postopno odstranijo iz telesa z biološkimi procesi.
English: The proliferation of these abnormal B-lymphocytes is the cause of symptoms you may have.
Slovenian: Nastajanje teh nenormalnih limfocitov B je vzrok simptomom, ki jih morda imate.
English: Depending on the signs and symptoms of your disease, your doctor will decide when you should receive more Rixathon.
Slovenian: Glede na znake in simptome vaše bolezni se bo zdravnik odločil, kdaj boste ponovno zdravljeni z zdravilom Rixathon.
English: - prepared in a laminar flow hood or biological safety cabinet using standard precautions for the safe handling of intravenous agents.
Slovenian: - biti pripravljeno v komori z laminarnim pretokom zraka ali v biološki varnostni komori, z uporabo standardnih previdnostnih ukrepov za varno ravnanje z intravenskimi zdravili.
English: Very Rare Not known
Slovenian: Zelo redki Neznana
English: Patients reporting signs and symptoms of infection following Rixathon therapy should be promptly evaluated and treated appropriately.
Slovenian: Bolnike, pri katerih se pojavijo znaki in simptomi okužbe po zdravljenju z zdravilom Rixathon, je treba nemudoma pregledati in primerno zdraviti.
English: The HCP educational leaflets and the Patient educational leaflet will be agreed with the National Competent Authorities prior to distribution.
Slovenian: O izobraževalnih letakih za zdravstvenega delavca in izobraževalnih letakih za bolnika bo pred razdelitvijo dogovorjeno z nacionalnim organom, pristojnim za zdravila.
English: EULAR response (%)
Slovenian: Odziv po EULAR (%)
English: • low mood and loss of interest or enjoyment in doing things, feeling nervous
Slovenian: • slabo razpoloženje in izguba zanimanja ali veselja za početje stvari, živčnost,
English: Therefore patients with a history of cardiac disease and/or cardiotoxic chemotherapy should be monitored closely.
Slovenian: Zato je treba bolnike z anamnezo srčne bolezni in/ali kardiotoksične kemoterapije skrbno nadzorovati.
English: 6336 Langkampfen Austria
Slovenian: 6336 Langkampfen AVSTRIJA
English: 6336 Langkampfen AUSTRIA
Slovenian: 6336 Langkampfen Avstrija
English: Following reconstitution of the immune system in immunocompromised patients with PML, stabilisation or improved outcome has been seen.
Slovenian: Po okrevanju imunskega sistema pri imunsko oslabljenih bolnikih s PML so opazili stabilizacijo ali izboljšanje izida.
English: The incidence of infections that were serious or required intravenous antibiotics was approximately 4 per 100 patient years.
Slovenian: Incidenca okužb, ki so bile resne ali so zahtevale uporabo intravenskega antibiotika, je bila približno 4 na 100 bolnik-let.
English: The most frequently reported events were tachycardia (4%) and atrial fibrillation (3%) (see section 4.4).
Slovenian: Najpogosteje opisana neželena učinka sta bila tahikardija (4 %) in atrijska fibrilacija (3 %) (glejte poglavje 4.4).
English: The alert card contains important safety information for patients regarding potential increased risk of infections, including progressive multifocal leukoencephalopathy (PML).
Slovenian: Opozorilna kartica vsebuje za bolnika pomembne podatke o varnosti glede možnega povečanega tveganja za okužbe, vključno s progresivno multifokalno levkoencefalopatijo (PML).
English: Before you are given Rixathon you will be given other medicines (premedication) to prevent or reduce possible side effects.
Slovenian: Preden boste dobili zdravilo Rixathon, boste dobili druga zdravila (to imenujemo premedikacija) za preprečitev ali zmanjšanje možnih neželenih učinkov.
English: • tremors (shakiness, often in the hands)
Slovenian: • tremor (tresenje, pogosto tresenje rok),
English: • painful joints or back
Slovenian: • boleči sklepi ali hrbet,
English: 38 months
Slovenian: 38 mesecev NR
English: Rarely Rixathon can cause a serious brain infection, called “Progressive Multifocal Leukoencephalopathy” or PML.
Slovenian: Redko lahko zdravilo Rixathon povzroči resno možgansko okužbo, imenovano progresivna multifokalna levkoencefalopatija ali PML.